Evidence map›Paper›PMID 39461964›Full record

ArticleNPJ Parkinson's disease2024

Randomized crossover trial on motor and non-motor outcome of directional deep brain stimulation in Parkinson's disease.

Alireza Gharabaghi, Idil Cebi, Dallas Leavitt, Maximilian Scherer, Patrick Bookjans, Bastian Brunnett, Luka Milosevic, Daniel Weiss

Registry-linked trialAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03548506 (Subthalamic Steering for Therapy Optimization in Parkinson's Disease), which is not on this map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03548506 nacompletednot on this map

Subthalamic Steering for Therapy Optimization in Parkinson's Disease

TypeinterventionalSponsorUniversity Hospital TuebingenRan2018 to 2023Enrolled20ConditionsParkinson DiseaseArmsOmnidirectional Deep Brain Stimulation of STN, Directional Deep Brain Stimulation of STN
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alireza GharabaghiInstitute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, Tübingen, Germany. alireza.gharabaghi@uni-tuebingen.de.
Idil CebiInstitute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, Tübingen, Germany.
Dallas LeavittInstitute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0009-0007-5272-3998
Maximilian SchererInstitute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-5280-2828
Patrick BookjansInstitute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, Tübingen, Germany.
Bastian BrunnettInstitute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, Tübingen, Germany.
Luka MilosevicInstitute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-4051-5397
Daniel WeissCenter for Neurology, Department for Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research, University Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0003-0447-7132

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep brain stimulation (DBS) with electric field steering may avoid areas responsible for side effects. This prospective randomized cross-over trial compared omnidirectional (OS) and directional (DS) subthalamic DBS in 19 patients. Electromyographically measured rigidity was the primary outcome. Motor and non-motor scores were secondary outcomes. There were no significant differences between OS and DS. In the acute setting, both conditions improved motor scores compared to no stimulation. Motor symptoms improved after 3 weeks of OS relative to acute measurements, whereas they worsened under DS. The more ventral the active contact, and the less the motor improvement sweet spot was stimulated, the greater the benefit of DS over OS for executive function. Accurate OS of the dorsal subthalamic nucleus ensures motor and non-motor improvements. While DS can mitigate executive decline stemming from off-target stimulation, it may lead to worse motor outcomes. Larger, long-term studies are needed to confirm these findings. (Registration: subthalamic steering for therapy optimization in Parkinson's Disease ClinicalTrials.gov: NCT03548506, 2018-06-06).

Identifiers

PMID39461964
PMCPMC11513109

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.